Flow Method Safety Data Shows Strong Results

A team of researchers looked at a medical treatment. The treatment was for brain aneurysms. The study wanted to know if the treatment was safe. It used real-world information. It did not use only top hospitals. It did not use only perfect cases. It compared two kinds of aneurysm locations. One kind was on-label. The other kind was off-label.

The study looked at many patients. There were 329 patients in one group. There were 72 patients in the other group. The first group was on-label. The second group was off-label. The patients had an average age of 64.6 years. Their ages ranged from 27 to 86 years. The on-label aneurysms were a bit larger. The average size was 6.9 mm. The off-label ones were 6.2 mm. The difference was small. It was likely meaningful. The groups were otherwise very similar.

The main result looked at brain function. It used a score at discharge. The score was called the modified Rankin Scale. The results were similar. The on-label group had 94.1 percent good scores. The off-label group had 97.5 percent good scores. The difference was not significant. The p-value was 0.615. There were also no big differences in surgery problems. There were no big differences in later scores. There were no big differences in aneurysm healing at first check.

Some data was missing later. That made a final check hard. The team used a matching method. It made 68 patients in each group. The results still held. The treatment did not show a clear safety gap. The final healing check could not be fully done. The team could not close that gap.